WednesdayAug 17, 2022 10:00 am

Golden Matrix Group Inc. (NASDAQ: GMGI) Primed for Online Gambling Explosion in U.S.

Since the federal government stepped out of the way with laws, 6 states so far have legal online casino games, with 3 already topping $1.0 billion in annual revenueLas Vegas-based Golden Matrix Group has built a robust platform it customizes and white labels to international casino operators providing access to over 10,000 gamesWell-suited to curate systems for American operators, Golden Matrix has experienced a surge in sales in 2022 from its Asia-Pacific customers Americans have always embraced gambling, but it has only been in the last decade or so that they had any ease of access outside of traveling to…

Continue Reading

TuesdayAug 16, 2022 10:30 am

QSAM Biosciences Inc. (QSAM) Awarded Patent for Potential Breakthrough Bone Cancer Treatment

This is the third U.S. patent granted to QSAM, further strengthening its IP portfolio, which consists of 14 patents among three patent families.“CycloSam has potential to be a breakthrough therapy for both primary and secondary forms of bone cancer,” says QSAM CEO.Patent covers formulation and preparation of CycloSam in the U.S. QSAM Biosciences (OTCQB: QSAM) has been awarded a key patent for its exclusive radiopharmaceutical drug candidate, CycloSam(R). Granted by the U.S. Patent & Trademark Office, the patent “protects how CycloSam(R) is formulated and prepared, namely by using a nonradioactive kit that can be delivered and stored local to the administration…

Continue Reading

TuesdayAug 16, 2022 9:45 am

Cepton, Inc. (NASDAQ: CPTN) Announces New COO Appointment; Reveals Attendance at J.P. Morgan Auto Conference

Dr. Liqun Han has been appointed as Cepton’s COO, having led the Company’s product development, commercialization, and operations teams over the past several yearsThe announcement marks a momentous year for the Company, with Cepton recently revealing that it had opened an expanded office within the Metro Detroit area to strengthen its engagements with automotive OEMsCepton attended the J.P. Morgan Auto Conference on August 10, 2022, where they hosted a live presentation for potential investors and other interested parties Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance MMT(R) lidar solutions, announced that they appointed Dr. Han to the…

Continue Reading

MondayAug 15, 2022 10:00 am

Golden Matrix Group Inc. (NASDAQ: GMGI) Reports a Record $9 Million in Quarterly Revenues

Golden Matrix Group Inc revealed that revenues for the third fiscal quarter ending July 21, 2022, exceeded $9 millionThe record top-line result marks a significant, 177% increase on a year-over-year basisManagement attributed the strong performance to continued growth within the company’s B2B and B2C segments, noting that there were approximately 635 operators and 6.5mn registered users across its platforms at the present juncture Golden Matrix Group (NASDAQ: GMGI), a developer and licensor of online gaming platforms, systems, and gaming content, set a record for the third fiscal quarter ended July 21, 2022, reporting revenues exceeding $9 million – equivalent to…

Continue Reading

ThursdayAug 11, 2022 10:15 am

Golden Matrix Group Inc. (NASDAQ: GMGI) Leverages Latest Tech Trends as Gamblers Continue Moving Online

Physical casino visits never recovered from COVID-19 restrictionsOnline gambling industry growing rapidly at CAGR of 11.7 percent from 2022 to 2030, expected to reach $153.6 billion by 2030Esports, social gaming, online poker tournaments, relaxed legislation driving user growthGMGI offers B2B partners access to 10,000+ games from over 25 leading game providers, aims to launch Esports betting platform Recent technological advances have made online gambling easier, more convenient, and more enjoyable for some users when compared to a physical casino experience. Golden Matrix Group (NASDAQ: GMGI), a developer and licensor of online gaming platforms, systems, and gaming content, continues to leverage…

Continue Reading

TuesdayAug 09, 2022 9:00 am

Mullen Automotive Inc. (NASDAQ: MULN) Signs ‘Milestone’ Agreement with Amazon Delivery Partner for Fleet of EV Vans

Mullen signed a binding agreement with DelPack Logistics for up to 600 Mullen Class 2 Electric Cargo VansThe agreement “puts our Class 1 cargo van program front and center for last-mile delivery opportunities,” says Mullen CEOA recent study indicated the last-mile delivery market in North America is projected to see incremental growth of $59.81 billion between 2020 and 2025 In the competitive electric vehicle (“EV”) world, Mullen Automotive (NASDAQ: MULN) stands apart. The Southern California–based company owns and partners with several synergistic businesses to create clean and scalable electric vehicles and energy solutions. The company’s ability to reach this goal can perhaps be measured by…

Continue Reading

FridayAug 05, 2022 9:45 am

Lidar Pioneer and Cepton, Inc. (NASDAQ: CPTN) CEO Dr. Jun Pei Aims to Make Driving Safer with Lidar

Lidar provides high-precision 3D imaging that helps enable hands-free driving, autonomous vehicles, smart cities, robotics, and other smart infrastructure applicationsCepton CEO Dr. Jun Pei, a pioneer who led the development of the revolutionary lidar during his tenure at Velodyne, was one of the first to focus on the ADAS market to bring lidar to the mass marketLidar is expected to be a $50B+ market by 2030 and Cepton’s technology will be in select General Motors cars starting next yearCepton recently grew its presence in Detroit with a new center of excellence and aims to expand active engagements and initiatives with…

Continue Reading

FridayAug 05, 2022 9:00 am

Mullen Automotive Inc. (NASDAQ: MULN) Anticipates Strongest Balance Sheet Ever as EV Industry Projected to See Double-Digit Growth

A recent Facts & Factors study reported that the global EV market is expected to pass $980 billion by 2028Mullen posted the strongest balance sheet in company history for the quarter ended June 30, 2022The company noted several key milestones in its journey to becoming a major presence in the EV world If Mullen Automotive (NASDAQ: MULN) latest financial report is any indication, the double-digit growth projected for the electric vehicle (“EV”) industry is right on the money. The emerging electric vehicle manufacturer posted a record balance sheet for the quarter ended June 30, 2022 (https://ibn.fm/RmJq8). A recent Facts &…

Continue Reading

ThursdayAug 04, 2022 10:00 am

Esports Market to Hit $12.5 Billion by 2030, Golden Matrix Group Inc. (NASDAQ: GMGI) To Add New Platform to Growing B2B iGaming Portfolio

Esports industry maturing, attracting growing audience via star-studded tournaments, ticket sales, merchandise, live social media eventsIndustry expected to reach $12.5 billion at a CAGR of 21.9% by 2030GMGI recently featured on Benzinga’s Esports Listmakers Series, CEO reveals upcoming launch of Esports platformGMGI delivers easily customizable, configurable, modular solutions for B2B operators, recently achieved 15 consecutive profitable quarters The global Esports market is maturing into a multi-faceted entertainment enterprise, complete with tournaments, celebrities, and social media influencers. Golden Matrix Group (NASDAQ: GMGI), a developer and licensor of online gaming platforms, systems, and gaming content, aims to leverage this trend by adding…

Continue Reading

ThursdayAug 04, 2022 9:00 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Advances Drug Candidate to Fight Aggressive Brain Cancer Amid Difficult Era for Market

CNS Pharmaceuticals is a U.S.-based drug innovator developing novel chemotherapy agents capable of taking the fight against cancerous tumors across the blood-brain barrier to directly attack cancerous growths of the central nervous system The company’s lead candidate is an anthracycline named Berubicin, which has previously shown promise among glioblastoma (“GBM”) patients in a safety study — particularly for one who remains cancer-free more than 15 years laterCNS is enrolling patients in the United States, Italy, France, Spain, and Switzerland, for the global Phase 2 clinical trial to measure Berubicin’s potential to match or exceed the effectiveness of Lomustine, a standard-of-care chemotherapy…

Continue Reading

Contact us: (512) 354-7000